2016 Q4 Form 10-Q Financial Statement

#000114420416131744 Filed on November 04, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q3
Revenue $12.84M $15.14M
YoY Change -6.39% 2.08%
Cost Of Revenue $9.930M $11.19M
YoY Change -17.04% -5.49%
Gross Profit $2.910M $3.950M
YoY Change 67.24% 32.11%
Gross Profit Margin 22.67% 26.09%
Selling, General & Admin $140.0K $200.0K
YoY Change -17.65% 5.26%
% of Gross Profit 4.81% 5.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $760.0K $713.0K
YoY Change 7.04% 11.06%
% of Gross Profit 26.12% 18.05%
Operating Expenses $10.07M $11.40M
YoY Change -17.04% -5.24%
Operating Profit $2.007M $3.029M
YoY Change -119.3% 40.1%
Interest Expense -$2.900M -$1.840M
YoY Change -24.08% -26.4%
% of Operating Profit -144.49% -60.75%
Other Income/Expense, Net -$2.946M -$30.00K
YoY Change -25.23% -98.85%
Pretax Income -$939.0K $1.110M
YoY Change -69.46% -344.49%
Income Tax -$377.0K $440.0K
% Of Pretax Income 39.64%
Net Earnings -$571.0K $600.0K
YoY Change -67.89% -310.53%
Net Earnings / Revenue -4.45% 3.96%
Basic Earnings Per Share
Diluted Earnings Per Share -$780.8K $821.9K
COMMON SHARES
Basic Shares Outstanding 734.2K shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.310M $3.810M
YoY Change -30.42% 115.25%
Cash & Equivalents $2.314M $3.814M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $880.0K $2.230M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.190M $6.040M
YoY Change -28.31% 46.6%
LONG-TERM ASSETS
Property, Plant & Equipment $36.58M $37.07M
YoY Change -3.53% 5.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.120M $7.250M
YoY Change -6.23% -17.89%
Other Assets $12.57M $8.750M
YoY Change 28.0% -69.65%
Total Long-Term Assets $55.47M $56.29M
YoY Change -2.69% -26.14%
TOTAL ASSETS
Total Short-Term Assets $3.190M $6.040M
Total Long-Term Assets $55.47M $56.29M
Total Assets $58.66M $62.33M
YoY Change -4.55% -22.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.13M $12.36M
YoY Change 4.82% -1.36%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.13M $12.36M
YoY Change 4.82% -1.36%
LONG-TERM LIABILITIES
Long-Term Debt $125.1M $126.0M
YoY Change -0.6% -11.37%
Other Long-Term Liabilities $830.0K
YoY Change
Total Long-Term Liabilities $126.0M $126.0M
YoY Change 0.06% -11.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.13M $12.36M
Total Long-Term Liabilities $126.0M $126.0M
Total Liabilities $133.5M $132.2M
YoY Change 0.35% -14.98%
SHAREHOLDERS EQUITY
Retained Earnings -$76.97M
YoY Change
Common Stock $2.092M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$74.88M -$69.84M
YoY Change
Total Liabilities & Shareholders Equity $58.66M $62.33M
YoY Change -4.55% -22.41%

Cashflow Statement

Concept 2016 Q4 2015 Q3
OPERATING ACTIVITIES
Net Income -$571.0K $600.0K
YoY Change -67.89% -310.53%
Depreciation, Depletion And Amortization $760.0K $713.0K
YoY Change 7.04% 11.06%
Cash From Operating Activities $2.920M $4.410M
YoY Change 167.89% -281.48%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K $1.291M
YoY Change -96.89% -1.75%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$50.00K -$1.290M
YoY Change -96.89% -1.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.930M -380.0K
YoY Change -9750.0% -108.52%
NET CHANGE
Cash From Operating Activities 2.920M 4.410M
Cash From Investing Activities -50.00K -1.290M
Cash From Financing Activities -1.930M -380.0K
Net Change In Cash 940.0K 2.740M
YoY Change -288.0% 280.56%
FREE CASH FLOW
Cash From Operating Activities $2.920M $4.410M
Capital Expenditures -$50.00K $1.291M
Free Cash Flow $2.970M $3.119M
YoY Change 10.0% -183.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2015Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1941000 USD
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1988000 USD
CY2015Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
104000 USD
CY2016Q3 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
262000 USD
CY2015Q3 prsi Net Unrealized Loss On Other Investments
NetUnrealizedLossOnOtherInvestments
19000 USD
CY2016Q3 prsi Net Unrealized Loss On Other Investments
NetUnrealizedLossOnOtherInvestments
0 USD
CY2015Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-30000 USD
CY2016Q3 prsi Impairment Loss On Other Investments
ImpairmentLossOnOtherInvestments
5000 USD
CY2015Q3 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
129000 USD
CY2016Q3 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
211000 USD
CY2015Q3 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-19000 USD
CY2016Q3 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
0 USD
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
713000 USD
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
664000 USD
CY2015Q3 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-142000 USD
CY2016Q3 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
640000 USD
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
12109000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3531000 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
11074000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
154000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
203000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3029000 USD
CY2015Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4562000 USD
CY2016Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-206000 USD
CY2015Q3 us-gaap Revenues
Revenues
15138000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
11396000 USD
CY2015Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-381000 USD
CY2016Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1308000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2737000 USD
CY2015Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-222000 USD
CY2016Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-327000 USD
CY2015Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2263000 USD
CY2016Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3144000 USD
CY2015Q3 prsi Increase Decrease In Due To Securities Broker
IncreaseDecreaseInDueToSecuritiesBroker
0 USD
CY2016Q3 prsi Increase Decrease In Due To Securities Broker
IncreaseDecreaseInDueToSecuritiesBroker
250000 USD
CY2015Q3 prsi Increase Decrease In Obligations For Securities Sold
IncreaseDecreaseInObligationsForSecuritiesSold
0 USD
CY2016Q3 prsi Increase Decrease In Obligations For Securities Sold
IncreaseDecreaseInObligationsForSecuritiesSold
339000 USD
CY2015Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
443000 USD
CY2016Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
705000 USD
CY2015Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4409000 USD
CY2016Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-427000 USD
CY2015Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1291000 USD
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
272000 USD
CY2015Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1291000 USD
CY2016Q3 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-272000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2007000 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1077000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3814000 USD
CY2015Q3 us-gaap Interest Paid
InterestPaid
1941000 USD
CY2016Q3 us-gaap Interest Paid
InterestPaid
1997000 USD
CY2016Q3 prsi Conversion Of Other Investments To Marketable Securities
ConversionOfOtherInvestmentsToMarketableSecurities
0 USD
CY2015Q3 prsi Conversion Of Other Investments To Marketable Securities
ConversionOfOtherInvestmentsToMarketableSecurities
4410000 USD
CY2015Q3 prsi Adjustment To Impairment Loss On Other Investments
AdjustmentToImpairmentLossOnOtherInvestments
0 USD
CY2016Q3 prsi Adjustment To Impairment Loss On Other Investments
AdjustmentToImpairmentLossOnOtherInvestments
5000 USD
CY2015Q3 us-gaap Trading Securities Realized Gain Loss
TradingSecuritiesRealizedGainLoss
-25000 USD
CY2016Q3 us-gaap Trading Securities Realized Gain Loss
TradingSecuritiesRealizedGainLoss
51000 USD
CY2015Q3 us-gaap Net Realized Or Unrealized Gain Loss On Trading Securities
NetRealizedOrUnrealizedGainLossOnTradingSecurities
104000 USD
CY2016Q3 us-gaap Net Realized Or Unrealized Gain Loss On Trading Securities
NetRealizedOrUnrealizedGainLossOnTradingSecurities
262000 USD
CY2016Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1206000 USD
CY2016Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1138000 USD
CY2016Q3 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
354000 USD
CY2016Q3 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
-5000 USD
CY2016Q3 us-gaap Revenues
Revenues
14605000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
10410000 USD
CY2016Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
234000 USD
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
55000 USD
CY2015Q3 us-gaap Assets
Assets
62332000 USD
CY2016Q3 dei Document Type
DocumentType
10-Q
CY2016Q3 dei Amendment Flag
AmendmentFlag
false
CY2016Q3 dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
CY2016Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2016Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q3 dei Entity Registrant Name
EntityRegistrantName
PORTSMOUTH SQUARE INC
CY2016Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000079661
CY2016Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2016Q3 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q3 dei Trading Symbol
TradingSymbol
PRSI
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
734183 shares
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-789000 USD
CY2015Q3 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-257000 USD
CY2016Q3 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-519000 USD
CY2015Q3 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-124000 USD
CY2016Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
734183 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
734183 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
734183 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
734183 shares
CY2016Q2 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
359000 USD
CY2015Q3 us-gaap Gain Loss On Sale Of Other Investments
GainLossOnSaleOfOtherInvestments
0 USD
CY2016Q3 prsi Other Investments In Nonmarketable Securities Ownership Percentage
OtherInvestmentsInNonmarketableSecuritiesOwnershipPercentage
less than 20%
CY2016Q3 prsi Percentage Of Loan Fee Received
PercentageOfLoanFeeReceived
0.03 pure

Files In Submission

Name View Source Status
0001144204-16-131744-index-headers.html Edgar Link pending
0001144204-16-131744-index.html Edgar Link pending
0001144204-16-131744.txt Edgar Link pending
0001144204-16-131744-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
prsi-20160930.xml Edgar Link completed
prsi-20160930.xsd Edgar Link pending
prsi-20160930_cal.xml Edgar Link unprocessable
prsi-20160930_def.xml Edgar Link unprocessable
prsi-20160930_lab.xml Edgar Link unprocessable
prsi-20160930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v451697_10q.htm Edgar Link pending
v451697_ex31-1.htm Edgar Link pending
v451697_ex31-2.htm Edgar Link pending
v451697_ex32-1.htm Edgar Link pending
v451697_ex32-2.htm Edgar Link pending